Radiofrequency ablation of hepatic tumors: Lessons learned from 3000 procedures

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 10, 2008, Pages 1492-1500

  Rhim, Hyunchul ^a   Lim, Hyo K ^a   Kim, Young Sum ^a   Choi, Dongil ^a   Lee, Won Jae ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Hepatocellular carcinoma; Image guided tumor ablation; Interventional oncology; Radiofrequency ablation; Ultrasound guided thermal ablation

Indexed keywords

CANCER CONTROL; CANCER SURVIVAL; HEALTH CARE QUALITY; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; REVIEW; SAFETY; SURVIVAL RATE; TREATMENT PLANNING;

EID: 53349092077     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05550.x     Document Type: Review

References (85)

1. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2005 9 : 191 211.
2. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985 56 : 918 28.
3. Stuart KE, Anad AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996 77 : 2217 22.
4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208 36.
5. Hong K, Geordiades CS, Geschwind JFH. Technology insight: image-guided therapies for hepatocellular carcinoma-intra-arterial and ablative techniques. Oncology 2006 3 : 315 24.
6. Jansen MC, Hillegersberg RV, Chamuleau RFFM et al. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur. J. Surg. Oncol. 2005 31 : 331 44.
7. Poon RT, Fat ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann. Surg. 2002 235 : 466 86.
8. Dodd GD III., Soulen MC, Kane RA et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000 20 : 9 27.
9. Pang RW, Poon RT. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 2007 72 (Suppl. 1 30 44.
10. Chen MH, Wei Y, Yan K et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J. Vasc. Interv. Radiol. 2006 17 : 671 83.
11. Lim HK. Radiofrequency thermal ablation of hepatocellular carcinomas. Korean J. Radiol. 2000 1 : 175 84.
12. Lim HK, Choi D, Lee WJ et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001 221 : 447 54.
13. Choi D, Lim HK, Kim SH et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radiofrequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J. Ultrasound Med. 2002 21 : 391 401.
14. Choi D, Lim HK, Kim SH et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000 217 : 558 63.
15. Kim TS, Lim HK, Kim H. Imaging-guided percutaneous radiofrequency ablation of pulmonary metastatic nodules caused by hepatocellular carcinoma: preliminary experience. AJR Am. J. Roentgenol. 2003 181 : 491 4.
16. Kim SK, Lim HK, Kim YH et al. Hepatocellular carcinoma treated with radiofrequency ablation: spectrum of imaging findings. Radiographics 2003 23 : 107 21.
17. Choi D, Lim HK, Lee WJ et al. Early assessment of the therapeutic response to radiofrequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J. Ultrasound Med. 2003 22 : 1163 72.
18. Rhim H, Yoon KH, Lee JM et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics 2003 23 : 123 34 discussion 134-6.
19. Kim SH, Lim HK, Choi D et al. Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am. J. Roentgenol. 2004 183 : 1611 7.
20. Choi D, Lim HK, Kim MJ et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR Am. J. Roentgenol. 2004 183 : 1417 24.
21. Choi D, Lim HK, Lee WJ et al. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography. Korean J. Radiol. 2004 5 : 185 98.
22. Choi D, Lim HK, Rhim H et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004 230 : 135 41.
23. Kim CK, Choi D, Lim HK et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur. J. Radiol. 2005 56 : 66 73.
24. Choi D, Lim HK, Kim MJ et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am. J. Roentgenol. 2005 184 : 1860 7.
25. Hong SN, Lee SY, Choi MS et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J. Clin. Gastroenterol. 2005 39 : 247 52.
26. Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann. Surg. Oncol. 2007 14 : 2319 29.
27. Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur. Radiol. 2007 17 : 684 92.
28. Choi D, Lim HK, Joh JW et al. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann. Surg. Oncol. 2007 14 : 3510 8.
29. Rhim H, Lim HK, Kim YS, Choi D, Lee KT. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am. J. Roentgenol 2008 190 : 1544 51.
30. Kim YS, Rhim H, Lim HK et al. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen. J. Comput. Assist. Tomogr. 2006 30 : 578 82.
31. Kim MH, Choi MS, Choi YS et al. Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma. Korean J. Hepatol. 2006 12 : 55 64.
32. Kim SH, Lim HK, Choi D et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am. J. Roentgenol. 2006 186 : S327 33.
33. Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J. Gastroenterol. Hepatol. 2007 Oct 17 Epub ahead of print YS, Rhim H, Lim HK, Choi D, Lee WJ, Kim SH. Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode. J. Vasc. Interv. Radiol. 2007 18 : 1126 33.
34. Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, Park CK. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur. Radiol. 2007 18 : 814 21.
35. Rhim H, Goldberg SN, Dodd GB 3rd. et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 2001 21 Spec No : S17 35.
36. Lecioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005 234 : 961 7.
37. Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005 103 : 1201.
38. Livraghi T, Meloni F, DiStasi M et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2007 47 : 82 9.
39. Yan K, Chen MH, Yang W et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors. Eur. J. Radiol. 2007 67 : 336 47.
40. Livraghi T, Solbiati L, Meloni MF et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003 226 : 441 51.
41. Wakabayashi H, Ushiyama T, Ishimura K et al. Significance of reduction surgery in multidisciplinary treatment of advance hepatocellular carcinoma with multiple intrahepatic lesions. J. Surg. Oncol. 2003 82 : 98 103.
42. Raut CP, Izzo F, Marra P et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann. Surg. Oncol. 2005 12 : 616 28.
43. Elias D, de Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumor recurrence after hepatectomy. Br. J. Surg. 2002 89 : 752 6.
44. Lu MD, Yin XY, Xie XY et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br. J. Surg. 2005 92 : 1393 8.
45. Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 2006 243 : 321 8.
46. Lu MD, Kuang M, Liang LJ et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006 86 : 801 5.
47. McGahan JP, Dodd GD III. Radiofrequency ablation of the liver: current status. AJR Am. J. Roentgenol. 2001 176 : 3 16.
48. Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005 235 : 728 39.
49. Schwartz ME, Sung ME, Mor E et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J. Am. Coll. Surg. 1995 180 : 596 603.
50. Chen MH. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom. Imaging 2008 33 : 428 36.
51. Mulier S, Mulier P, Ni Y et al. Complications of radiofrequency coagulation of liver tumours. Br. J. Surg. 2002 89 : 1206 22.
52. Rhim H, Dodd DG III., Chintapalli KN et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 2004 24 : 41 52.
53. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom. Imaging 2005 30 : 409 18.
54. Kim SK, Rhim H, Kim YS et al. Radiofrequency thermal ablation of hepatic tumors: pitfalls and challenges. Abdom. Imaging 2005 30 : 727 33.
55. Machi J, Uchida S, Sumida K et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J. Gastrointest. Surg. 2001 5 : 477 89.
56. Koda M, Ueki M, Maeda Y et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am. J. Roentgenol. 2004 183 : 583 8.
57. de Baere T, Dromain C, Lapeyre M et al. Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience. Radiology 2005 236 : 666 70.
58. Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am. J. Roentgenol. 2008 190 : 91 8.
59. Laeseke PF, Sampson LA, Brace CL, Winter TC 3rd., Fine JP, Lee FT Jr. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am. J. Roentgenol. 2006 186 (5 Suppl. S249 54.
60. Hinshaw JL, Laeseke PF, Winter TC 3rd., Kliewer MA, Fine JP, Lee FT Jr. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am. J. Roentgenol. 2006 186 (Suppl. 5 S306 10.
61. Rhim H, Dodd GD III. Radiofrequency thermal ablation of liver tumors. J. Clin. Ultrasound 1999 27 : 221 9. Review.
62. Takahashi S, Kudo M, Chung H et al. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007 72 (Suppl. 1 98 103.
63. Nakazawa T, Kokubu S, Shibuya A et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am. J. Roentgenol. 2007 188 : 480 8.
64. Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur. J. Radiol. 2006 59 : 432 41.
65. Frich L, Hagen G, Brabrab K et al. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis. J. Vasc. Interv. Radiol. 2007 18 : 1134.
66. Dupuy DE, Goldberg SN Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J. Vasc. Interv. Radiol. 2001 12 : 1135 48.
67. Lencinoni R, Della Pina C, Bartolozzi C. Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom. Imaging 2005 30 : 401 8.
68. Frericks BB, Ritz JP, Roggan A, Wolf KJ, Albrecht T. Multipolar radiofrequency ablation of hepatic tumors: initial experience. Radiology 2005 237 : 1056 62.
69. Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the 'heat sink' effect. AJR Am. J. Roentgenol. 2002 1787 : 47 51.
70. Kim SK, Lim HK, Ryu JA et al. Radiofrequency ablation of rabbit liver in vivo: effect of the pringle maneuver on pathologic changes in liver surrounding the ablation zone. Korean J. Radiol. 2004 5 : 240.
71. Patterson EJ, Scudamore CH, Owen DA et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann. Surg. 1998 227 : 559 65.
72. Zhang YJ, Liang HH, Chen MS et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology 2007 244 : 599.
73. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur. Radiol. 2006 16 : 661 9.
74. Meloni MF, Goldberg SN, Livraghi T et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am. J. Roentgenol. 2001 177 : 375 80.
75. Crocetti L, Lencioni R, Debeni S et al. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system. Invest. Radiol. 2008 43 : 33 9.
76. Minami Y, Kudo M, Chung H et al. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007 72 (Suppl. 1 111 6.
77. Wood BJ, Locklin JK, Remer E, O'Malley CM, Goldfarb D, Kaouk JH. Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J. Vasc. Interv. Radiol. 2007 18 : 9 24.
78. Paudyal B, Oriucho N, Paudyal P et al. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol. Rep. 2007 18 : 1469.
79. Hakime A, Hines-Peralta A, Peddi H et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology 2007 244 : 464 70.
80. Solazzo SA, Ahmed M, Liu Z, Hines-Peralta AU, Goldberg SN. High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings. Radiology 2007 242 : 743 50.
81. Goldberg SN, Kamel IR, Kruskal JB et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am. J. Roentgenol. 2002 179 : 93 101.
82. Weng DS, Zhou J, Zhou QM et al. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas. J. Immunother. 2008 31 : 63 71.
83. Fagnoni FF, Zerbibi A, Pelosi G, Missale G. Combination of radiofrequency ablation and immunotherapy. Front. Biosci. 2008 1 : 369 81.
84. El-Seraq HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008 134 : 1752 63.
85. Ng KK, Poon RT. Current treatment strategy for hepatocellular carcinoma. Saudi Med. J. 2007 28 : 1330 8.